| Ankur S Fadia, MD | |
|
127 Mcclanahan St Sw, Carilion Clinic Cardiology Fellowship Program, Roanoke, VA 24014-1728 | |
| (540) 224-1008 | |
| (540) 527-1039 |
| Full Name | Ankur S Fadia |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 13 Years |
| Location | 127 Mcclanahan St Sw, Roanoke, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063701076 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 0101254294 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Page Memorial Hospital, Inc | Luray, VA | Hospital |
| Wythe County Community Hospital | Wytheville, VA | Hospital |
| Lewisgale Hospital Alleghany | Low moor, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Coverage Corp | 3072412592 | 364 |
| Ingleside Emergency Group Llc | 1355698317 | 20 |
| Page Memorial Hospital Inc | 8426951203 | 43 |
News Archive
Malaria kills a child every thirty seconds in Sub-Saharan Africa, according to recent estimates. It is a huge problem currently threatening over 40% of the world's population and still on the increase.
United BioSource Corporation today announced the launch of a new office in Lörrach, Germany, further expanding the company's clinical research and medical affairs capabilities in Europe. The Lörrach office is located near Basel, Switzerland and is the 10th UBC office to open in Europe, adding to facilities in the United Kingdom, Switzerland, Ukraine, Spain, Sweden, Hungary and the Czech Republic.
Researchers at Massachusetts General Hospital found that patients with nonalcoholic fatty liver disease (NAFLD) who carry an allele of the PNPLA3 gene have an increased risk of developing advanced disease, including nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. A second study supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) validates these findings and further concludes that in pediatric patients, the same allele is associated with earlier disease presentation.
InterMune, Inc. today announced the publication of results from two Phase 3 trials demonstrating that treatment with pirfenidone, a novel antifibrotic and anti-inflammatory drug, was associated with favorable effects on lung function, 6-minute walk test distance and progression-free survival (PFS) in patients with mild to moderate idiopathic pulmonary fibrosis (IPF).
AMIA, the association for professionals in biomedical and health informatics, sent comments to the federal Office of the National Coordinator on Health Information Technology (DHHS/ ONCHIT), which has actively supported and incentivized the adoption and meaningful use of electronic health records (EHRs) over the last year, and which solicited comment, through the HIT Policy Committee (HITPC), on the continuation of support for achieving meaningful use of EHRs in 2013 and 2014.
› Verified 7 days ago
| Entity Name | Shenandoah Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952417735 PECOS PAC ID: 2466360375 Enrollment ID: O20040115001156 |
News Archive
Malaria kills a child every thirty seconds in Sub-Saharan Africa, according to recent estimates. It is a huge problem currently threatening over 40% of the world's population and still on the increase.
United BioSource Corporation today announced the launch of a new office in Lörrach, Germany, further expanding the company's clinical research and medical affairs capabilities in Europe. The Lörrach office is located near Basel, Switzerland and is the 10th UBC office to open in Europe, adding to facilities in the United Kingdom, Switzerland, Ukraine, Spain, Sweden, Hungary and the Czech Republic.
Researchers at Massachusetts General Hospital found that patients with nonalcoholic fatty liver disease (NAFLD) who carry an allele of the PNPLA3 gene have an increased risk of developing advanced disease, including nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. A second study supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) validates these findings and further concludes that in pediatric patients, the same allele is associated with earlier disease presentation.
InterMune, Inc. today announced the publication of results from two Phase 3 trials demonstrating that treatment with pirfenidone, a novel antifibrotic and anti-inflammatory drug, was associated with favorable effects on lung function, 6-minute walk test distance and progression-free survival (PFS) in patients with mild to moderate idiopathic pulmonary fibrosis (IPF).
AMIA, the association for professionals in biomedical and health informatics, sent comments to the federal Office of the National Coordinator on Health Information Technology (DHHS/ ONCHIT), which has actively supported and incentivized the adoption and meaningful use of electronic health records (EHRs) over the last year, and which solicited comment, through the HIT Policy Committee (HITPC), on the continuation of support for achieving meaningful use of EHRs in 2013 and 2014.
› Verified 7 days ago
| Entity Name | Page Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326040684 PECOS PAC ID: 8426951203 Enrollment ID: O20040129000420 |
News Archive
Malaria kills a child every thirty seconds in Sub-Saharan Africa, according to recent estimates. It is a huge problem currently threatening over 40% of the world's population and still on the increase.
United BioSource Corporation today announced the launch of a new office in Lörrach, Germany, further expanding the company's clinical research and medical affairs capabilities in Europe. The Lörrach office is located near Basel, Switzerland and is the 10th UBC office to open in Europe, adding to facilities in the United Kingdom, Switzerland, Ukraine, Spain, Sweden, Hungary and the Czech Republic.
Researchers at Massachusetts General Hospital found that patients with nonalcoholic fatty liver disease (NAFLD) who carry an allele of the PNPLA3 gene have an increased risk of developing advanced disease, including nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. A second study supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) validates these findings and further concludes that in pediatric patients, the same allele is associated with earlier disease presentation.
InterMune, Inc. today announced the publication of results from two Phase 3 trials demonstrating that treatment with pirfenidone, a novel antifibrotic and anti-inflammatory drug, was associated with favorable effects on lung function, 6-minute walk test distance and progression-free survival (PFS) in patients with mild to moderate idiopathic pulmonary fibrosis (IPF).
AMIA, the association for professionals in biomedical and health informatics, sent comments to the federal Office of the National Coordinator on Health Information Technology (DHHS/ ONCHIT), which has actively supported and incentivized the adoption and meaningful use of electronic health records (EHRs) over the last year, and which solicited comment, through the HIT Policy Committee (HITPC), on the continuation of support for achieving meaningful use of EHRs in 2013 and 2014.
› Verified 7 days ago
| Entity Name | Emergency Coverage Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427005008 PECOS PAC ID: 3072412592 Enrollment ID: O20050418000414 |
News Archive
Malaria kills a child every thirty seconds in Sub-Saharan Africa, according to recent estimates. It is a huge problem currently threatening over 40% of the world's population and still on the increase.
United BioSource Corporation today announced the launch of a new office in Lörrach, Germany, further expanding the company's clinical research and medical affairs capabilities in Europe. The Lörrach office is located near Basel, Switzerland and is the 10th UBC office to open in Europe, adding to facilities in the United Kingdom, Switzerland, Ukraine, Spain, Sweden, Hungary and the Czech Republic.
Researchers at Massachusetts General Hospital found that patients with nonalcoholic fatty liver disease (NAFLD) who carry an allele of the PNPLA3 gene have an increased risk of developing advanced disease, including nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. A second study supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) validates these findings and further concludes that in pediatric patients, the same allele is associated with earlier disease presentation.
InterMune, Inc. today announced the publication of results from two Phase 3 trials demonstrating that treatment with pirfenidone, a novel antifibrotic and anti-inflammatory drug, was associated with favorable effects on lung function, 6-minute walk test distance and progression-free survival (PFS) in patients with mild to moderate idiopathic pulmonary fibrosis (IPF).
AMIA, the association for professionals in biomedical and health informatics, sent comments to the federal Office of the National Coordinator on Health Information Technology (DHHS/ ONCHIT), which has actively supported and incentivized the adoption and meaningful use of electronic health records (EHRs) over the last year, and which solicited comment, through the HIT Policy Committee (HITPC), on the continuation of support for achieving meaningful use of EHRs in 2013 and 2014.
› Verified 7 days ago
| Entity Name | Southwestern Virginia Mental Health Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912964347 PECOS PAC ID: 3577571041 Enrollment ID: O20060324000094 |
News Archive
Malaria kills a child every thirty seconds in Sub-Saharan Africa, according to recent estimates. It is a huge problem currently threatening over 40% of the world's population and still on the increase.
United BioSource Corporation today announced the launch of a new office in Lörrach, Germany, further expanding the company's clinical research and medical affairs capabilities in Europe. The Lörrach office is located near Basel, Switzerland and is the 10th UBC office to open in Europe, adding to facilities in the United Kingdom, Switzerland, Ukraine, Spain, Sweden, Hungary and the Czech Republic.
Researchers at Massachusetts General Hospital found that patients with nonalcoholic fatty liver disease (NAFLD) who carry an allele of the PNPLA3 gene have an increased risk of developing advanced disease, including nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. A second study supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) validates these findings and further concludes that in pediatric patients, the same allele is associated with earlier disease presentation.
InterMune, Inc. today announced the publication of results from two Phase 3 trials demonstrating that treatment with pirfenidone, a novel antifibrotic and anti-inflammatory drug, was associated with favorable effects on lung function, 6-minute walk test distance and progression-free survival (PFS) in patients with mild to moderate idiopathic pulmonary fibrosis (IPF).
AMIA, the association for professionals in biomedical and health informatics, sent comments to the federal Office of the National Coordinator on Health Information Technology (DHHS/ ONCHIT), which has actively supported and incentivized the adoption and meaningful use of electronic health records (EHRs) over the last year, and which solicited comment, through the HIT Policy Committee (HITPC), on the continuation of support for achieving meaningful use of EHRs in 2013 and 2014.
› Verified 7 days ago
| Entity Name | Apogee Medical Group Virginia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861660540 PECOS PAC ID: 0345310256 Enrollment ID: O20080604000498 |
News Archive
Malaria kills a child every thirty seconds in Sub-Saharan Africa, according to recent estimates. It is a huge problem currently threatening over 40% of the world's population and still on the increase.
United BioSource Corporation today announced the launch of a new office in Lörrach, Germany, further expanding the company's clinical research and medical affairs capabilities in Europe. The Lörrach office is located near Basel, Switzerland and is the 10th UBC office to open in Europe, adding to facilities in the United Kingdom, Switzerland, Ukraine, Spain, Sweden, Hungary and the Czech Republic.
Researchers at Massachusetts General Hospital found that patients with nonalcoholic fatty liver disease (NAFLD) who carry an allele of the PNPLA3 gene have an increased risk of developing advanced disease, including nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. A second study supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) validates these findings and further concludes that in pediatric patients, the same allele is associated with earlier disease presentation.
InterMune, Inc. today announced the publication of results from two Phase 3 trials demonstrating that treatment with pirfenidone, a novel antifibrotic and anti-inflammatory drug, was associated with favorable effects on lung function, 6-minute walk test distance and progression-free survival (PFS) in patients with mild to moderate idiopathic pulmonary fibrosis (IPF).
AMIA, the association for professionals in biomedical and health informatics, sent comments to the federal Office of the National Coordinator on Health Information Technology (DHHS/ ONCHIT), which has actively supported and incentivized the adoption and meaningful use of electronic health records (EHRs) over the last year, and which solicited comment, through the HIT Policy Committee (HITPC), on the continuation of support for achieving meaningful use of EHRs in 2013 and 2014.
› Verified 7 days ago
| Entity Name | Ingleside Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144712662 PECOS PAC ID: 1355698317 Enrollment ID: O20180720002968 |
News Archive
Malaria kills a child every thirty seconds in Sub-Saharan Africa, according to recent estimates. It is a huge problem currently threatening over 40% of the world's population and still on the increase.
United BioSource Corporation today announced the launch of a new office in Lörrach, Germany, further expanding the company's clinical research and medical affairs capabilities in Europe. The Lörrach office is located near Basel, Switzerland and is the 10th UBC office to open in Europe, adding to facilities in the United Kingdom, Switzerland, Ukraine, Spain, Sweden, Hungary and the Czech Republic.
Researchers at Massachusetts General Hospital found that patients with nonalcoholic fatty liver disease (NAFLD) who carry an allele of the PNPLA3 gene have an increased risk of developing advanced disease, including nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. A second study supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) validates these findings and further concludes that in pediatric patients, the same allele is associated with earlier disease presentation.
InterMune, Inc. today announced the publication of results from two Phase 3 trials demonstrating that treatment with pirfenidone, a novel antifibrotic and anti-inflammatory drug, was associated with favorable effects on lung function, 6-minute walk test distance and progression-free survival (PFS) in patients with mild to moderate idiopathic pulmonary fibrosis (IPF).
AMIA, the association for professionals in biomedical and health informatics, sent comments to the federal Office of the National Coordinator on Health Information Technology (DHHS/ ONCHIT), which has actively supported and incentivized the adoption and meaningful use of electronic health records (EHRs) over the last year, and which solicited comment, through the HIT Policy Committee (HITPC), on the continuation of support for achieving meaningful use of EHRs in 2013 and 2014.
› Verified 7 days ago
| Entity Name | Ingleside Physician Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932693488 PECOS PAC ID: 6103174255 Enrollment ID: O20180806001778 |
News Archive
Malaria kills a child every thirty seconds in Sub-Saharan Africa, according to recent estimates. It is a huge problem currently threatening over 40% of the world's population and still on the increase.
United BioSource Corporation today announced the launch of a new office in Lörrach, Germany, further expanding the company's clinical research and medical affairs capabilities in Europe. The Lörrach office is located near Basel, Switzerland and is the 10th UBC office to open in Europe, adding to facilities in the United Kingdom, Switzerland, Ukraine, Spain, Sweden, Hungary and the Czech Republic.
Researchers at Massachusetts General Hospital found that patients with nonalcoholic fatty liver disease (NAFLD) who carry an allele of the PNPLA3 gene have an increased risk of developing advanced disease, including nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. A second study supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) validates these findings and further concludes that in pediatric patients, the same allele is associated with earlier disease presentation.
InterMune, Inc. today announced the publication of results from two Phase 3 trials demonstrating that treatment with pirfenidone, a novel antifibrotic and anti-inflammatory drug, was associated with favorable effects on lung function, 6-minute walk test distance and progression-free survival (PFS) in patients with mild to moderate idiopathic pulmonary fibrosis (IPF).
AMIA, the association for professionals in biomedical and health informatics, sent comments to the federal Office of the National Coordinator on Health Information Technology (DHHS/ ONCHIT), which has actively supported and incentivized the adoption and meaningful use of electronic health records (EHRs) over the last year, and which solicited comment, through the HIT Policy Committee (HITPC), on the continuation of support for achieving meaningful use of EHRs in 2013 and 2014.
› Verified 7 days ago
| Entity Name | Kingsford Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871088526 PECOS PAC ID: 0840541017 Enrollment ID: O20180927000385 |
News Archive
Malaria kills a child every thirty seconds in Sub-Saharan Africa, according to recent estimates. It is a huge problem currently threatening over 40% of the world's population and still on the increase.
United BioSource Corporation today announced the launch of a new office in Lörrach, Germany, further expanding the company's clinical research and medical affairs capabilities in Europe. The Lörrach office is located near Basel, Switzerland and is the 10th UBC office to open in Europe, adding to facilities in the United Kingdom, Switzerland, Ukraine, Spain, Sweden, Hungary and the Czech Republic.
Researchers at Massachusetts General Hospital found that patients with nonalcoholic fatty liver disease (NAFLD) who carry an allele of the PNPLA3 gene have an increased risk of developing advanced disease, including nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. A second study supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) validates these findings and further concludes that in pediatric patients, the same allele is associated with earlier disease presentation.
InterMune, Inc. today announced the publication of results from two Phase 3 trials demonstrating that treatment with pirfenidone, a novel antifibrotic and anti-inflammatory drug, was associated with favorable effects on lung function, 6-minute walk test distance and progression-free survival (PFS) in patients with mild to moderate idiopathic pulmonary fibrosis (IPF).
AMIA, the association for professionals in biomedical and health informatics, sent comments to the federal Office of the National Coordinator on Health Information Technology (DHHS/ ONCHIT), which has actively supported and incentivized the adoption and meaningful use of electronic health records (EHRs) over the last year, and which solicited comment, through the HIT Policy Committee (HITPC), on the continuation of support for achieving meaningful use of EHRs in 2013 and 2014.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ankur S Fadia, MD Po Box 13367, Carilion Clinic Cardiology Fellowship Program, Roanoke, VA 24033-3367 Ph: (540) 224-1008 | Ankur S Fadia, MD 127 Mcclanahan St Sw, Carilion Clinic Cardiology Fellowship Program, Roanoke, VA 24014-1728 Ph: (540) 224-1008 |
News Archive
Malaria kills a child every thirty seconds in Sub-Saharan Africa, according to recent estimates. It is a huge problem currently threatening over 40% of the world's population and still on the increase.
United BioSource Corporation today announced the launch of a new office in Lörrach, Germany, further expanding the company's clinical research and medical affairs capabilities in Europe. The Lörrach office is located near Basel, Switzerland and is the 10th UBC office to open in Europe, adding to facilities in the United Kingdom, Switzerland, Ukraine, Spain, Sweden, Hungary and the Czech Republic.
Researchers at Massachusetts General Hospital found that patients with nonalcoholic fatty liver disease (NAFLD) who carry an allele of the PNPLA3 gene have an increased risk of developing advanced disease, including nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. A second study supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) validates these findings and further concludes that in pediatric patients, the same allele is associated with earlier disease presentation.
InterMune, Inc. today announced the publication of results from two Phase 3 trials demonstrating that treatment with pirfenidone, a novel antifibrotic and anti-inflammatory drug, was associated with favorable effects on lung function, 6-minute walk test distance and progression-free survival (PFS) in patients with mild to moderate idiopathic pulmonary fibrosis (IPF).
AMIA, the association for professionals in biomedical and health informatics, sent comments to the federal Office of the National Coordinator on Health Information Technology (DHHS/ ONCHIT), which has actively supported and incentivized the adoption and meaningful use of electronic health records (EHRs) over the last year, and which solicited comment, through the HIT Policy Committee (HITPC), on the continuation of support for achieving meaningful use of EHRs in 2013 and 2014.
› Verified 7 days ago
Dr. Jed David Gonzalo, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3 Riverside Cir, Roanoke, VA 24016 Phone: 540-224-5170 | |
Dr. Adel M Salama, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111b S Jefferson St, Roanoke, VA 24016 Phone: 540-342-1007 Fax: 540-345-4643 | |
Dr. Daniel Frank Pauly, , M.D., PH.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2001 Crystal Spring Ave Sw Ste 203, Roanoke, VA 24014 Phone: 540-982-8204 | |
Joshua Gabriel Gazo, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1906 Belleview Ave Se, Roanoke, VA 24014 Phone: 540-981-7000 | |
Joseph L. Austin, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 127 Mcclanahan St Sw, Suite 300, Roanoke, VA 24014 Phone: 540-982-8204 Fax: 540-224-1059 | |
Ali M Yahya, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2213 Stanley Ave Se, Roanoke, VA 24014 Phone: 571-338-9463 | |
Umar Sofi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2001 Crystal Spring Ave Sw Ste 300, Roanoke, VA 24014 Phone: 540-985-8505 Fax: 540-344-3313 |